| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 12/24/2008 | WO2008157324A2 Peptide linked cell matrix materials for stem cells and methods of using the same |
| 12/24/2008 | WO2008156807A2 Antithrombotic agents and methods of use thereof |
| 12/24/2008 | WO2008156661A2 BACTERIAL MEDIATED TNF-α GENE SILENCING |
| 12/24/2008 | WO2008156629A2 Methods and agents for inhibiting tumor growth by targeting the ssdna replication intermediate of tumor stem cells |
| 12/24/2008 | WO2008156172A1 Double-stranded nucleic acid molecule, cancer cell proliferation inhibitor and pharmaceutical agent suitable for prevention or treatment of uterine cancer, breast cancer and bladder cancer |
| 12/24/2008 | WO2008156153A1 Preventive/remedy for cancer |
| 12/24/2008 | WO2008156012A1 CANCER REMEDY CONTAINING MORTALIN siRNA |
| 12/24/2008 | WO2008155122A1 Targeted provision of recombinase activity by trans-splicing |
| 12/24/2008 | WO2008118386A3 Method for detecting autoprocessed, secreted pcsk9 |
| 12/24/2008 | WO2008097503A3 Use of semaphorin 6a for promoting myelination and oligodendrocyte differentiation |
| 12/24/2008 | WO2008067279A3 Biological pacemakers including mutated hyperpolarization-activated cyclic nucleotide-gated (hcn) channels |
| 12/24/2008 | WO2007130726A3 Methods for the detection of cancer |
| 12/24/2008 | EP2006681A1 Rheumatoid arthritis test method and treating method |
| 12/24/2008 | EP2006303A1 Recombinant antibodies specific for Beta-Amyloid ends, DNA encoding and methods of use thereof |
| 12/24/2008 | EP2006300A2 Characterization of a calcium channel family |
| 12/24/2008 | EP2006294A1 Tumour-associated peptides that bind to MHC molecules |
| 12/24/2008 | EP2006293A2 2'-hydroxyl-modified ribonucleoside derivative |
| 12/24/2008 | EP2004823A2 Treatment of cns conditions |
| 12/24/2008 | EP2004239A2 Novel integrin binding rgd-lipopeptides with gene transfer activities |
| 12/24/2008 | EP2004141A2 An efficient method for loading amphoteric liposomes with nucleic acid active substances |
| 12/24/2008 | EP1732614B1 Compositions for treating neuropathic and neurodegenerative conditions |
| 12/24/2008 | EP1549340B1 Biofunctional cpg or oligo-/polynucleotide and toxin or enterotoxin containing composition |
| 12/24/2008 | EP1328291B1 Viruses targeted to hypoxic cells and tissues |
| 12/24/2008 | EP1178785B1 Compositions and methods for identifying antigens which elicit an immune response |
| 12/24/2008 | EP1003773B1 Ctl epitopes of epstein-barr virus |
| 12/24/2008 | DE102007028441A1 Gezielte Bereitstellung von Rekombinase-Aktivität durch Trans-Spleißen Targeted delivery of recombinase activity by trans-splicing |
| 12/24/2008 | CN101331231A Compounds and methods for peptide ribonucleic acid condensate particles for RNA therapeutics |
| 12/24/2008 | CN101328199A SiRNA inhibiting human cell cycle protein A2 expression and use thereof |
| 12/24/2008 | CN101327324A Method and composition for treating autoimmunity disease |
| 12/24/2008 | CN100445381C Preparation method for siRNA molecule with single chain polyA tail and application thereof |
| 12/24/2008 | CN100445380C Therapeutically useful synthetic oligonucleotides |
| 12/24/2008 | CA2692072A1 Methods and agents for inhibiting tumor growth |
| 12/24/2008 | CA2690271A1 Chlamydia antigens |
| 12/24/2008 | CA2688145A1 A method of treating abnormal angiogenesis via the bai family of proteins and their protein fragments |
| 12/23/2008 | US7468431 Modulation of eIF4E-BP2 expression |
| 12/23/2008 | US7468430 Transposase and method of gene modification |
| 12/23/2008 | US7468352 Mutated anthrax toxin protective antigen proteins that specifically target cells containing high amounts of cell-surface metalloproteinases or plasminogen activator receptors |
| 12/23/2008 | US7468277 Enriched preparation of human fetal multipotential neural stem cells |
| 12/23/2008 | US7468276 Bloodless mammalian placenta for use in generating multipotent stem cells |
| 12/23/2008 | US7468275 Synthetic internal ribosome entry sites and methods of identifying same |
| 12/23/2008 | US7468273 Canine GHRH gene, polypeptides and methods of use |
| 12/23/2008 | US7468242 skin components having three dimensional structure of the tissue from which they are derived, and having dimensions so as to allow diffusion of nutrients, gases and wastes to and from cells |
| 12/23/2008 | US7468181 Means and methods for the production of adenovirus vectors |
| 12/23/2008 | CA2379003C Therapy of respiratory influenza virus infection using free and liposome-encapsulated ribonucleotides |
| 12/23/2008 | CA2364499C Means and methods for fibroblast-like or macrophage-like cell transduction |
| 12/23/2008 | CA2334520C Treatment of immune diseases |
| 12/23/2008 | CA2285298C Complexes comprising local anesthetic and nucleic acid and method of making and using the same |
| 12/18/2008 | WO2008154482A2 Sirna compositions and methods of use in treatment of ocular diseases |
| 12/18/2008 | WO2008154333A2 Mir-34 regulated genes and pathways as targets for therapeutic intervention |
| 12/18/2008 | WO2008153733A2 Vectors and methods for genetic immunization |
| 12/18/2008 | WO2008153692A2 Microrna expression profiling of cerebrospinal fluid |
| 12/18/2008 | WO2008153299A1 Method for rejuvenating isolated pancreatic islets for transplantation |
| 12/18/2008 | WO2008153072A1 Gene sensitive to bone/joint disease and use thereof |
| 12/18/2008 | WO2008152636A2 Compositions and methods for inhibiting nadph oxidase expression |
| 12/18/2008 | WO2008151841A2 Treatment for alzheimer' s disease |
| 12/18/2008 | WO2008151434A1 Small cationic antimicrobial peptides |
| 12/18/2008 | WO2008151428A1 Novel compositions for modulating mrna translation |
| 12/18/2008 | WO2008151388A1 Methods of initiating insulin production |
| 12/18/2008 | WO2008131191A3 Nucleic acids hybridizable to micro rna and precursors thereof |
| 12/18/2008 | WO2008125846A3 Genetic suppression and replacement |
| 12/18/2008 | WO2008097927A3 Treatment and prevention of neurodegenerative diseases using gene therapy |
| 12/18/2008 | WO2008070448A3 Cancer-specific promoters |
| 12/18/2008 | WO2008030610A3 Human transcriptome corresponding to human oocytes and use of said genes or the corresponding polypeptides to trans-differentiate somatic cells |
| 12/18/2008 | WO2007098060A3 Methods and agents for modulating an immune response |
| 12/18/2008 | WO2007095345A3 Methods and compositions for regulation of neurological conditions |
| 12/18/2008 | WO2006002416A3 Methods and means for increasing resistance to cell damage |
| 12/18/2008 | WO2006002203A8 Methods and compositions for the treatment of polycystic diseases |
| 12/18/2008 | US20080312426 Chicken leukemia inhibitory factor (LIF) and GNNE thereof |
| 12/18/2008 | US20080312417 Ucp5 |
| 12/18/2008 | US20080312177 Serca2 therapeutic compositions and methods of use |
| 12/18/2008 | US20080312173 Treatment of HSV-related pathologies using plasmids that make ssDNA |
| 12/18/2008 | US20080312146 METH1 and METH2 Polynucleotides and Polypeptides |
| 12/18/2008 | US20080312143 Modified Cdna for High Expression Levels of Factor VIII and Its Derivatives |
| 12/18/2008 | US20080312134 Vesicles for active macromolecule delivery |
| 12/18/2008 | US20080312130 Drug delivery vehicle for cancer therapy, process for producing the same, and pharmaceutical preparation using the same |
| 12/18/2008 | US20080312129 Use of Mas G-Protein-Coupled Receptor Agonists and Antagonists, as Apoptotic-Activity Modulators for Study, Prevention and Treatment of Diseases |
| 12/18/2008 | US20080311654 Effective as an anti-differentiator while the chicken differentiable cell is being cultured; enables stable supply of the LIF protein derived from chickens |
| 12/18/2008 | US20080311576 Replication competent hepatitis C virus and methods of use |
| 12/18/2008 | US20080311126 Antisense Oligonucleotides Directed to Ribonucleotide Reducatase R2 and Uses Thereof in Combination Therapies for the Treatment of Cancer |
| 12/18/2008 | US20080311124 Nucleotide sequences coding tumor polypeptides for use in diagnosis, prevention and treatment of cell proliferative disorders |
| 12/18/2008 | US20080311123 Compositions and methods for the therapy and diagnosis of breast cancer |
| 12/18/2008 | US20080311121 Antibody antagonists of ve-cadherin without adverse effects on vascular permeability |
| 12/18/2008 | US20080311109 Nucleotide sequences coding tumor polypeptides for use in diagnosis, prevention and treatment of cell proliferative disorders |
| 12/18/2008 | US20080311106 Product Comprising a C4bp Core Protein and a monomeric Antigen, and Its Use |
| 12/18/2008 | US20080311091 Engineered Dopamine Neurons and Uses Thereof |
| 12/18/2008 | US20080311045 Polymersomes for Use in Acoustically Mediated Intracellular Drug Delivery in vivo |
| 12/18/2008 | CA2690267A1 Small cationic antimicrobial peptides |
| 12/18/2008 | CA2689974A1 Mir-34 regulated genes and pathways as targets for therapeutic intervention |
| 12/17/2008 | EP2003207A2 Antisense inhibition of PTP1B expression |
| 12/17/2008 | EP2003202A2 G protein-coupled receptor up-regulated in prostate cancer and uses thereof |
| 12/17/2008 | EP2003201A2 Compounds and methods for therapy and diagnosis of lung cancer |
| 12/17/2008 | EP2003140A2 Galactose derivative, drug carrier and medicinal composition |
| 12/17/2008 | EP2001517A2 Regulated expression of recombinant proteins from adeno-associated viral vectors |
| 12/17/2008 | EP2001516A2 Vaccine for viruses that cause persistent or latent infections |
| 12/17/2008 | EP1843791A4 Treatment of degenerative diseases with the x-linked inhibitor of apoptosis |
| 12/17/2008 | EP1622673B1 System for the delivery of a biologic therapy with device monitoring and back-up |
| 12/17/2008 | EP1572889B1 Nucleic acid and amino acid sequences encoding high-level expressor factor viii polypeptides and methods of use |
| 12/17/2008 | EP1230214B1 Novel genes tzap7/a, tzap7/b and tzap7 involved in t cell activation and uses thereof |
| 12/17/2008 | EP1007673B1 Novel bone mineralization proteins, dna, vectors, expression systems |
| 12/17/2008 | EP0975810B1 Method of pcr testing of pooled blood samples |